首页> 外国专利> CONTAINER OF MEDICINAL AGENTS FOR TREATMENT AND PROPHYLAXIS OF GASTROENTERIC DISEASES CAUSED OR MEDIATED BY INFECTION WITH HELICOBACTER PYLORI

CONTAINER OF MEDICINAL AGENTS FOR TREATMENT AND PROPHYLAXIS OF GASTROENTERIC DISEASES CAUSED OR MEDIATED BY INFECTION WITH HELICOBACTER PYLORI

机译:幽门螺杆菌感染引起或介导的治疗和预防胃肠道疾病的药用试剂的容器

摘要

FIELD: medicine, gastroenterology, pharmacy. SUBSTANCE: invention proposed the combined preparation for treatment and prophylaxis of gastroenteric diseases caused or mediated by microorganism Helicobacter pylori. The preparation consists of two rows of medicinal agents placed separately in a single container unit and including omeprazole or lansoprazole, tinidazol or metronidazole, clarithromycin designated for the combined simultaneous or successive oral administration. Proposed combinations of components provide synergetic antibacterial effect against Helicobacter pylori in vitro and in vivo in experiments with white inbred mice. Except for, the application of preparation allows avoiding the repeated infection. Disposition of active components in container provides maximal acid-resistance of omeprazole and lansoprazole and their convenient using by patient. EFFECT: improved and valuable properties of container. 2 cl, 1 tbl, 1 dwg, 5 ex
机译:领域:医学,胃肠病学,药学。物质:本发明提出了用于治疗和预防由幽门螺杆菌引起或介导的胃肠道疾病的联合制剂。该制剂由两排分别放在一个容器单元中的药物组成,包括奥美拉唑或兰索拉唑,替硝唑或甲硝唑,克拉霉素,指定用于同时或连续口服联合给药。提议的组分组合在用白色近交小鼠进行的实验中,在体外和体内均可对幽门螺杆菌产生协同抗菌作用。除此之外,制剂的使用可以避免重复感染。放置在容器中的活性成分可最大程度地抵抗奥美拉唑和兰索拉唑的酸,并方便患者使用。效果:容器的改进和有价值的特性。 2 cl,1 tbl,1 dwg,5 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号